Neuro-Cells stem-cell treatment for traumatic spinal cord injury [ID6588]

Status:

Suspended

Technology type:

Medicine

Decision:

Selected

Reason for decision:

Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in use addressed, and help them make the best use of NHS resources

Rationale:

Dear stakeholders, For information, the company have not provided any information regarding their Marketing Authorisation Application from the Medicines and Healthcare products Regulatory Agency (MHRA) for this indication at this time. Therefore, NICE has decided to suspend this appraisal from its current work programme.

Process:

STA Standard

ID number:

6588

Email enquiries

If you have any queries please email topic.selection@nice.org.uk

Timeline

Key events during the development of the guidance:

For further information on our processes and methods, please see our CHTE processes and methods manual